| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Medical Officer | Common Stock, par value $0.001 per share | 0 | $0 | $23.46 | 02 Jun 2025 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Chief Medical Officer | Restricted Stock Units | 268,136 | 20 Nov 2025 | Direct | ||
| CATALYST PHARMACEUTICALS, INC. | Chief Medical Officer | Options to purchase common stock | 238,360 | 20 Nov 2025 | Direct | ||
| Flexion Therapeutics Inc | Chief Medical Officer | Common Stock | 0 | $8.50 | 19 Nov 2021 | Direct | |
| Flexion Therapeutics Inc | Chief Medical Officer | Stock option (right to buy) | 0 | 19 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS, INC. | 20 Nov 2025 | 2 | $0 | 4 | Chief Medical Officer | 24 Nov 2025, 20:08 |
| CPRX | CATALYST PHARMACEUTICALS, INC. | 02 Jun 2025 | 0 | $0 | 3 | Chief Medical Officer | 06 Jun 2025, 17:00 |
| /report/000120919121065704-andrews-william-t-2021-11-19 | Flexion Therapeutics Inc | 19 Nov 2021 | 2 | -$291,125 | 4 | Chief Medical Officer | 19 Nov 2021, 08:58 |
| /report/000120919121049605-andrews-william-t-2021-08-02 | Flexion Therapeutics Inc | 02 Aug 2021 | 2 | $0 | 4 | Chief Medical Officer | 04 Aug 2021, 16:09 |
| /report/000120919121045490-andrews-william-t-2021-07-01 | Flexion Therapeutics Inc | 01 Jul 2021 | 0 | $0 | 3 | Chief Medical Officer | 06 Jul 2021, 16:34 |